Cano Health's Q2 Miss and Restructuring: Shares Take a Hit
- August 11th, 2023
- 287 views
Cano Health, Inc. (NYSE: CANO) reported a Q2 2023 loss of $(0.51) per share, which fell short of the consensus estimate loss of $(0.12). The company's quarterly sales were also below expectations, totaling $766.70 million while analysts projected $828.43 million for the period.
Cano Health also unveiled plans to sell itself, accompanied by the decision to discontinue operations in California, New Mexico, Illinois by fall 2023, and Puerto Rico by the end of the year. The company is implementing a comprehensive operational restructuring plan aimed at enhancing efficiency and reducing costs. As part of this restructuring, Cano Health is projected to downsize its workforce by about 700 employees, which constitutes 17% of its total workforce, in the third quarter of 2023.
$CANO was trading at $0.86 in pre-market, reflecting a significant decline of $0.66 or 43.42%
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY OR DIGITAL ASSET. Please consult with a professional investment advisor before purchasing or selling any securities viewed on or mentioned herein. (Read Full Disclaimer)
Tags
Post Your Comments
Want To Find Some News?
Recent Posts
-
A Preview: Oracle, Franco-Nevada, and Asana Earnings Due
March 09th, 2025NVIDIA, Salesforce, and Agilent Technologies Earnings Loom: What to Expect
February 23rd, 2025Key Reports Ahead: KBR, Hims & Hers Health, and Cleveland-Cliffs Earnings Preview
February 23rd, 2025Earnings On Deck: What to Expect from Copart, Cheniere Energy, and Insulet
February 16th, 2025
Member Login